Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Metabolic Profiling of Esketamine Treatment in Depressive Disorder

View source ↗

Summary

A clinical trial protocol evaluates metabolic profiling during Esketamine treatment for Major Depressive Disorder and is currently recruiting. The study is spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)

Snippet

Sponsor: University of Zagreb | Conditions: Major Depressive Disorder | Status: RECRUITING